One of the main limitations with medicine today and in the pharmaceutical industry is our understanding of the biology of disease. Here is where big data comes into play, aggregating more and more information around multiple scales for what constitutes a disease—from the DNA, proteins, and metabolites to cells, tissues, organs, organisms, and ecosystems. These […]
